(BS17) |
A new therapeutic target in the treatment of hypertrophic obstructive cardiomyopathy |
|
J. Tschudinowskikh, M. Eremeeva, T. Sukhachova, R. Serov, L. Bockeria (Moscow, RU) |
(BS18) |
Nucleoside Diphosphate Kinase C is a Critical Regulator of cAMP synthesis and Subsequent Gβγ Signaling in Cardiomyocytes |
|
I. Abu-Taha, N. M. Wolf, S. Lutz, A. El-Armouche, D. Dobrev, T. Wieland, H.-J. Hippe (Mannheim, Heidelberg, Göttingen) |
(BS19) |
Loss of phosphatase-inhibitor-1 exaggerates heart failure progression in CaMKIIδc transgenic mice |
|
C. Brammen, S. Neef, K. Wittköpper, T. Sowa, R. Blume, T. Schulte, W.-H. Zimmermann, L. S. Maier, A. El-Armouche (Göttingen) |
(BS20) |
Automated high-throughput microscopy and image analysis for the in vitro assessment of cardiomyocyte hypertrophy |
|
S. Leierseder, C. Jentzsch, S. Engelhardt (München) |
(BS21) |
Role of TRPC-channels for the development of cardiac hypertrophy based on the analysis of TRPC deficient mice |
|
J. E. Camacho Londono, M. Meissner, Q. Tian, K. Hammer, D. Alexander, L. Birnbaumer, V. Flockerzi, P. Lipp, M. Freichel (Homburg/Saar, München; Research Triangle Park, North Carolina, US) |
(BS22) |
Nuclear export of HDAC4 mediates histone demethylation at H3K9 with diminished HP1 binding in the promoter region of ANF in response to elevated preload |
|
M. Hohl, J.-C. Reil, M. Tauchnitz, A. M. Zimmer, S. A. Müller, J. Backs, M. Böhm, C. Maack (Homburg/Saar, Heidelberg) |
(BS23) |
Entwicklung eines kausal-therapeutischen Ansatz für die dilatative Kardiomyopathie mittels DNA-Intereferenz |
|
M. Gramlich, Q. Zhou, L. Zha, M. Gawaz (Tübingen) |
(BS24) |
Cyclophilin A spielt eine wichtige Rolle bei der Makrophagen und T-Zellen-Rekrutierung in der Coxsackievirus B3-induzierten Myokarditis |
|
P. Seizer, K. Klingel, M. Sauter, C. Ochmann, T. Schönberger, R. Kandolf, M. Gawaz, A. May (Tübingen) |
(BS25) |
Analysis of AKT1 and AKT2-specific signal transduction by quantitative phosphoproteomics |
|
M. Reinartz, A. Raupach, N. Blasberg, A. Gödecke (Düsseldorf) |
(BS26) |
Cardiomyocyte-specific deletion of CaMKII delta and gamma protects against heart failure despite activation of Calcineurin |
|
M. Kreußer, L. H. Lehmann, S. Keranov, H. A. Katus, J. Backs (Heidelberg) |
(BS27) |
RhoA controls not only the morphology and secretory behavior of cardiac fibroblast, but also the stability of its microenvironment |
|
A. Jatho, C. A. Weis, C. Würtz, T. Wieland, S. Lutz (Göttingen, Mannheim) |
(BS28) |
Requirement of HDAC4 for angiotensin-II induced perivascular fibrosis |
|
C. Oeing, L. H. Lehmann, M. Kreußer, H. A. Katus, J. Backs (Heidelberg) |